BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Emotional wellness Matters: My Fight with Tension - 2The Way to Business: Startup Illustrations Learned
- 3Triple polar vortex to plunge central and eastern U.S. into Arctic cold through mid-December
- 4Jennifer Lawrence and Josh Hutcherson to reprise their roles for new 'Hunger Games' movie 'Sunrise on the Reaping'
- 5Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- The Drone Video of the Year is stunning – you've not seen Namibia like this
- Tech for Efficiency: Applications and Apparatuses to Accomplish More
- How a Middle East War Becomes a Retail Price Hike
- Flu is rising rapidly, driven by a new variant. Here's what to know
- The Effect of Online Organizations on Society: Beating the Difficulties
- Arctic sea ice hits lowest winter level as unprecedented heat hits smashes records all over Earth
- The most effective method to Amplify Profits from Gold Speculation: Systems and Tips
- Instructions to Floss Appropriately and Forestall Gum Sickness
- WATCH: IDF strikes, dismantles missile launchers in southern Lebanon
